ISTH/X
Jul 16, 2025, 14:57
ISTH SSC Launches Survey on Antithrombotic Therapy in Brain Tumor Patients
The International Society on Thrombosis and Haemostasis (ISTH) Scientific and Standardization Committee (SSC) shared a post on X:
“Are you an expert in neurosurgery or antithrombotic therapy? Take our 15-min survey on managing brain tumor patients with ICH + anticoagulation needs.”
Participate in the survey and contribute to the development of future clinical guidance.
Stay connected for more updates in thrombosis care at Hemostasis Today.
-
Apr 22, 2026, 15:47Mohammed Alo: Being Fit Does Not Protect You from High LDL
-
Apr 22, 2026, 15:28ASH Committee Brings the Voice of Hematology to Capitol Hill
-
Apr 22, 2026, 15:22Stephen Pendergast: Are Universal Shelf Stable Blood Substitutes Finally Within Reach?
-
Apr 22, 2026, 14:51Mavis Agnes Kisakye: Reconnecting to Drive the Global Bleeding Disorders Agenda Forward
-
Apr 22, 2026, 14:48Augustina Isioma Ikusemoro: Not Every Antigen Speaks Loudly, But the Right Test Will Hear It
-
Apr 22, 2026, 14:47Karuna Kumar: Busting the Myth about Increasing Infection Risk by IV Iron
-
Apr 22, 2026, 14:46David Brown: Charting a New Path Forward for One Patient Facing Extraordinary Cardiac Challenges
-
Apr 22, 2026, 14:45Ney Carter Borges: Syphilis and Cardiovascular Risk – A Silent and Progressive Vascular Burden
-
Apr 22, 2026, 14:44Sanjay Ahuja – New CEO and Medical Director of Innovative Hematology